𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes

✍ Scribed by F. Vánky; G. Stuber; J. Willems; K. Sjöwall; B. Larsson; K. Böök; T. Ivert; A. Péterffy; E. Klein


Publisher
Springer-Verlag
Year
1988
Tongue
English
Weight
959 KB
Volume
27
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Auto-tumor recognition following in vitr
✍ F. Vánky; G. Stuber; S. Rotstein; E. Klein 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 519 KB

Expression of major histocompatibility complex (MHC) class I antigens was induced in eight out of nine freshly prepared tumor cell suspensions by exposure to interferon (IFN gamma) and tumor necrosis factor (TNF alpha) in vitro. The untreated, class-I-antigen-negative, and the treated, antigen-posit

Human tumour—lymphocyte interaction in v
✍ B. M. Vose; F. Vánky; E. Klein 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 609 KB

## Abstract Lymphocytes prepared from the blood, tumour‐draining lymph node and tumour were tested for immune reactivity with freshly isolated autologous tumour cells from biopsies. Reactivity was assessed by the autologous tumour stimulation assay and by lymphocytotoxicity. Activity was found in 6

Tumor-specific CD8+ T lymphocytes derive
✍ Franck Housseau; Daniel A. Langer; Samuel D. Oberholtzer; Anitha Moorthy; Hyam I 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB 👁 2 views

## Abstract To identify tumor‐associated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge

Favorable outcome in clinically stage II
✍ Inge S. van Houdt; Berbel J.R. Sluijter; Laura M. Moesbergen; Wim M. Vos; Tanja 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 296 KB 👁 1 views

## Abstract In this study we investigated whether the presence of specific populations of tumor infiltrating lymphocytes (TILs) in diagnostic primary melanoma biopsies are related to outcome in clinically stage II melanoma patients. Moreover, we investigated whether the presence of TILs correlates